Combination of phenotype assessments and CYP2C9-VKORC1 polymorphisms in the determination of warfarin dose requirements in heavily medicated patients.
Michaud V, Vanier MC, Brouillette D, Roy D, Verret L, Noel N, Taillon I, O'Hara G, Gossard D, Champagne M, Goodman K, Renaud Y, Brown A, Phillips M, Ajami AM, Turgeon J.
Michaud V, et al.
Clin Pharmacol Ther. 2008 May;83(5):740-8. doi: 10.1038/sj.clpt.6100434. Epub 2007 Nov 14.
Clin Pharmacol Ther. 2008.
PMID: 18030307